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Conclusions: Ultradian biorhytms are not just a trend, and due to high-technologies 
developement, they may be used during diagnosis and during the treatement and planification of 
therapeutic maneuvers as well. It rests to elucidate, argumentate optimal, corect, economical and 
affordable methods of personalized determination of these rhythms.
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Introduction: Diabetes mellitus (DM) represents a group of pathological conditions that share the 
phenotype of hyperglycemia as the result of insulin deficiency or the disorders of insulin action. 90% of 
people with diabetes have type 2 diabetes (T2D), while type 1 diabetes (T1D) affects 10% of the patients. 
T1D has a strong autoimmune component, proved by the correlation with specific haplotypes of the 
HLA system. T2D develops mainly because of the -cell dysfunction and insulin resistance. There are 
rare forms of DM caused by genetic defects of -cell function, genetic defects of insulin action, diseases 
of the exocrine pancreas, endocrinopathies, diabetes induced by chemicals or infections. 
The epidemiological aspects of DM impress with its worldwide expansion and high prevalence in 
people. Severe vascular and neurologic complications of diabetes reduce the quality and duration of life, 
bringing an economic impact to the countries' budgets. We have performed a study which was aimed for 
the determination of the genetic background and the evolutional features of the disease in patients with 
DM. 
Materials and methods: The study was performed in the Department of Molecular Biology and 
Human Genetics, most of the patients being from the Department of Endocrinology, the Republican 
Clinical Hospital. We studied 34 clinical cases of DM: 19 male and 15 female patients, between 18 and 
80 years old; 10 with the diagnosis of T1D, and 24 with T2D. The questionnaire included the following 
aspects: the debut of the disease, the features of the objective and paraclinical examination, the evolution 
of DM including acute and chronic complications, family history and life style.
Discussion results: The study has shown the following results: genetic susceptibility can be 
observed more frequently in patients with T2D; T2D is Associated with obesity, arterial hypertension 
and dyslipidemia while patients with T1D have normal body mass index; T1D may be Associated with 
other autoimmune diseases, such as autoimmune thyroiditis or rheumatic cardiopathy; many patients 
with T2D treated with oral antidiabetic drugs had to Associate insulin to their therapy, so, -cell 
dysfunction plays an important role in T2D pathogenesis.
Conclusion: The pathogenesis of DM shows a strong genetic component Associated with life 
style features. So, it would be a great opportunity of preventing the disease and its complications by 
changing the habits in people with family history and genetic predisposition for DM. The principles of 
genomic medicine should be brought closed to the clinical medicine. The implementation of genetic 
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testing and personalized approach to the patients would reduce the cost of the treatment by reducing the 
incidence of DM. 
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Introduction: The immune process in the pathogenesis of the tumors represents an actual subject 
for the prevention and the treatment of the cancer, which frequency is decreasing while studying the 
newest theories of the etiopathology of cancer, a disease that is the common cause of death.
The objective of this study is to review the newest methods, that explain the role of the immune 
processes in the pathology and the treatment of tumors.
Material and methods: Informational support for the development of this publication has served 
a full amount of current national and international journals, which are concerned with tumors, found 
through the„PubMed” „Google” si „CrossRefMedlineWeb of Science”. After entering the filters: the 
immune process in the pathogenesis of tumors were selected 20 sources.
Results:After studying the interaction between the immune system and the tumors, different 
immunotherapies were identified: the new therapeutic monoclonal antibodies, that were approved by the 
Food and Drug Administration, as a standard treatment in some forms of cancer, Associated with 
trastuzumab for mamar cancer and rituximab for the B cells lymphoma, and the vaccines, which are 
starting to be used in clinical practice, either alone or in various combinations.
Conclusions: Much has been learned about the potential of the immune system to control cancer 
and the various ways that immunotherapy can boost the potential of the immune system for the benefit 
of the patient. This knowledge has stimulated the invention of many new therapeutic antibodies, cell-
based treatments, and vaccines, which are starting to be used in clinical practice, either alone or in 
various combinations. These new therapies are expected to result in improved cancer treatment and, 
eventually, the prevention of cancer. 
Key words: The hallmarks of cancer, the immunology of cancer, imunogenicity, 
immunosuppression, immunotherapies.
303. THE INFLUENCE OF EXPIRATION AND INSPIRATION DURATION ON 
RESPIRATORY HEART ARRHYTHMIA 
Iulia Temusco, Andrei Ganenco
Scientific adviser: Victor Vovc, MD, PhD, Professor, Nicolae Testemitanu State University of Medicine 
and Pharmacy, Chisinau, Republic of Moldova
292
